Michael Stowasser

Michael Stowasser's AcademicInfluence.com Rankings

Michael Stowasser

Engineering

#6504

World Rank

#7836

Historical Rank

Electrical Engineering

#1945

World Rank

#2047

Historical Rank

engineering Degrees

Michael Stowasser

Computer Science

#8580

World Rank

#9019

Historical Rank

Data Science

#204

World Rank

#208

Historical Rank

Computational Linguistics

#1940

World Rank

#1961

Historical Rank

Machine Learning

#3552

World Rank

#3596

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Michael Stowasser's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Mathematics University of California, Berkeley

Similar Degrees You Can Earn

Why Is Michael Stowasser Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael Stowasser's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. (2016) (1605)
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. (2008) (1133)
Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents (2004) (611)
HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION (1994) (505)
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. (2017) (473)
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. (2004) (363)
The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. (2012) (293)
High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients (2003) (284)
Effect of Aldosterone Antagonism on Myocardial Dysfunction in Hypertensive Patients With Diastolic Heart Failure (2004) (280)
A randomized trial of dietary sodium restriction in CKD. (2013) (253)
Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. (2005) (234)
Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study (2010) (190)
EVIDENCE THAT PRIMARY ALDOSTERONISM MAY NOT BE UNCOMMON: 12% INCIDENCE AMONG ANTIHYPERTENSIVE DRUG TRIAL VOLUNTEERS (1993) (185)
Primary aldosteronism—careful investigation is essential and rewarding (2004) (184)
A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22) (2000) (178)
Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. (2009) (172)
A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. (1995) (150)
Factors Affecting the Aldosterone/Renin Ratio (2011) (147)
Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. (2010) (138)
CLCN2 Chloride Channel Mutations in Familial Hyperaldosteronism Type II (2017) (137)
Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement (2012) (134)
Somatic Mutations Affecting the Selectivity Filter of KCNJ5 Are Frequent in 2 Large Unselected Collections of Adrenal Aldosteronomas (2012) (132)
CLINICAL AND PATHOLOGICAL DIVERSITY OF PRIMARY ALDOSTERONISM, INCLUDING A NEW FAMILIAL VARIETY (1991) (130)
Randomized Trial of Guiding Hypertension Management Using Central Aortic Blood Pressure Compared With Best-Practice Care: Principal Findings of the BP GUIDE Study (2013) (128)
Impact of Different Diagnostic Criteria During Adrenal Vein Sampling on Reproducibility of Subtype Diagnosis in Patients With Primary Aldosteronism (2010) (128)
FAMILIAL HYPERALDOSTERONISM TYPE II: FIVE FAMILIES WITH A NEW VARIETY OF PRIMARY ALDOSTERONISM (1992) (125)
Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. (2009) (111)
Diagnosis and management of primary aldosteronism: An updated review (2013) (108)
Cellular and Genetic Causes of Idiopathic Hyperaldosteronism (2018) (106)
Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney. (2016) (102)
A Randomised Controlled Trial of Medication Liaison Services—Patient Outcomes (2002) (98)
Primary aldosteronism: hypertension with a genetic basis (1992) (98)
Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? (2011) (95)
Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity (2005) (95)
Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. (2009) (88)
Australian association for exercise and sports science position statement on exercise and hypertension. (2009) (88)
Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. (1998) (87)
Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study. (2014) (86)
Success of Surgery for Primary Aldosteronism Judged by Residual Autonomous Aldosterone Production (1998) (86)
Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. (2011) (86)
Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension (2003) (85)
Central blood pressure measurement may improve risk stratification (2008) (84)
Laboratory investigation of primary aldosteronism. (2010) (83)
Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families (2008) (83)
Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement (2017) (78)
Review: Diagnosis and management of primary aldosteronism (2001) (78)
Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. (2000) (78)
Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. (2011) (77)
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism (2018) (72)
Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. (2015) (71)
Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. (2000) (70)
Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. (2011) (69)
Home blood pressure monitoring: Australian Expert Consensus Statement (2015) (67)
Guide to management of hypertension 2008 - Assessing and managing raised blood pressure in adults (2008) (65)
Primary aldosteronism: learning from the study of familial varieties. (2000) (65)
Primary aldosteronism: revival of a syndrome. (2001) (64)
Primary aldosteronism: Are we diagnosing and operating on too few patients? (2001) (62)
Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. (2000) (62)
New Perspectives On The Role Of Aldosterone Excess In Cardiovascular Disease (2001) (58)
Update in primary aldosteronism. (2009) (58)
RESPONSE TO UNILATERAL ADRENALECTOMY FOR ALDOSTERONE‐PRODUCING ADENOMA: EFFECT OF POTASSIUM LEVELS AND ANGIOTENSIN RESPONSIVENESS (1994) (58)
Role for Germline Mutations and a Rare Coding Single Nucleotide Polymorphism Within the KCNJ5 Potassium Channel in a Large Cohort of Sporadic Cases of Primary Aldosteronism (2014) (56)
The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism (2019) (54)
Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism (2018) (53)
Update in primary aldosteronism. (2009) (52)
Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism (2016) (52)
Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. (2013) (52)
Primary aldosteronism—some genetic, morphological, and biochemical aspects of subtypes (1995) (51)
In Primary Aldosteronism, Mineralocorticoids Influence Exosomal Sodium-Chloride Cotransporter Abundance. (2017) (50)
Allelic losses on chromosome band 11q13 in aldosterone‐producing adrenal tumors (1995) (49)
Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. (2005) (49)
The aldosterone-renin ratio in screening for primary aldosteronism (2004) (48)
Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. (1999) (47)
Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients. (2011) (46)
How common is primary aldosteronism? Is it the most frequent cause of curable hypertension? (1993) (46)
A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation? (2014) (46)
Aldosterone assays: an urgent need for improvement. (2006) (45)
Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism? (2016) (44)
A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients (2014) (44)
Waiting a few extra minutes before measuring blood pressure has potentially important clinical and research ramifications (2014) (44)
Effect of atenolol on aldosterone/renin ratio calculated by both plasma Renin activity and direct Renin concentration in healthy male volunteers. (2010) (43)
Masked hypertension is “unmasked” by low-intensity exercise blood pressure (2011) (42)
Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia (2001) (42)
Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome) (2013) (41)
EXAMINATION OF CHROMOSOME 7p22 CANDIDATE GENES RBaK, PMS2 AND GNA12 IN FAMILIAL HYPERALDOSTERONISM TYPE II (2008) (40)
Diaphragmatic paralysis following cervical herpes zoster (1990) (40)
Familial Forms Broaden the Horizons for Primary Aldosteronism (1998) (40)
Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II (2011) (39)
Diagnosis and management of primary aldosteronism. (2001) (38)
A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I. (1997) (38)
Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers (1999) (38)
PRODUCTION OF 18‐OXO‐CORTISOL IN SUBTYPES OF PRIMARY ALDOSTERONISM (1996) (38)
Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I (1995) (38)
Primary aldosteronism: from genesis to genetics (2003) (38)
Exercise and sport science australia position stand update on exercise and hypertension (2019) (37)
AN ASSOCIATION OF PRIMARY ALDOSTERONISM AND ADRENALINE‐SECRETING PHAEOCHROMOCYTOMA (1994) (37)
Arterial stiffness, central blood pressure and body size in health and disease (2012) (36)
Primary aldosteronism: Rare bird or common cause of secondary hypertension? (2001) (35)
Masked Hypertension is “Unmasked” by Low Intensity Exercise Blood Pressure (2009) (33)
Familial Varieties Of Primary Aldosteronism (2001) (33)
Hyperaldosteronism: primary versus tertiary. (2002) (32)
Familial hyperaldosteronism (2001) (32)
Simultaneous measurement of aldosterone and cortisol by high-performance liquid chromatography-tandem mass spectrometry: application to dehydration-rehydration studies. (2010) (32)
Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea (2017) (31)
Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis. (1993) (30)
The SPARTACUS Trial: Controversies and Unresolved Issues (2017) (30)
Adverse cardiovascular outcomes of corticosteroid excess. (2012) (29)
PCR‐SSCP ANALYSIS OF THE p53 GENE IN TUMOURS OF THE ADRENAL GLAND (1996) (29)
Mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo‐controlled cross‐over study (2018) (27)
Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism (2018) (27)
Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study (2015) (26)
Monogenic mineralocorticoid hypertension. (2006) (26)
PLASMA ALDOSTERONE RESPONSE TO ACTH IN SUBTYPES OF PRIMARY ALDOSTERONISM (1995) (26)
Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism. (2020) (25)
Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved? (2017) (24)
Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism? (2015) (24)
PCR‐SSCP ANALYSIS OF THE ANGIOTENSIN II TYPE 1: RECEPTOR GENE IN PATIENTS WITH ALDOSTERONE‐PRODUCING ADENOMAS (1995) (24)
Primary aldosteronism: the case for screening (2007) (24)
Salt, aldosterone and hypertension (2013) (23)
Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma (2013) (22)
ANGIOTENSIN‐RESPONSIVEALDOSTERONE‐PRODUCING ADENOMAS: POSTOPERATIVE DISAPPEARANCE OF ALDOSTERONE RESPONSE TO ANGIOTENSIN (1993) (22)
LAPAROSCOPIC ADRENALECTOMY FOR ADRENAL TUMOURS CAUSING HYPERTENSION AND FOR ‘INCIDENTALOMAS’ OF THE ADRENAL ON COMPUTERIZED TOMOGRAPHY SCANNING (1995) (22)
Facebook advertising for participant recruitment into a blood pressure clinical trial (2017) (22)
Blood Pressure Variability and Prediction of Target Organ Damage in Patients With Uncomplicated Hypertension. (2016) (22)
Expression of 11β-hydroxysteroid dehydrogenase type 2 (11βHSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma (1999) (22)
Prevalence and diagnostic workup of primary aldosteronism: new knowledge and new approaches (2001) (22)
Comparison of Central Blood Pressure Estimated by a Cuff-Based Device With Radial Tonometry. (2016) (21)
Hypertension Management Guide for Doctors 2004 (2004) (21)
Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison (2016) (21)
A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. (2015) (20)
Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test - Variability Between Immunoassay and HPLC-MS/MS. (2020) (20)
Effect of Combined Hormonal Replacement Therapy on the Aldosterone/Renin Ratio in Postmenopausal Women (2017) (20)
Primary aldosteronism: implications of a new familial variety. (1991) (20)
Familial or genetic primary aldosteronism and Gordon syndrome. (2011) (20)
Elevated Serum Interleukin 6 Levels in Normotensive Individuals With Familial Hyperaldosteronism Type 1 (2009) (20)
Effect of Moxonidine on the Aldosterone/Renin Ratio in Healthy Male Volunteers (2017) (19)
Reversible heart rhythm complexity impairment in patients with primary aldosteronism (2015) (19)
Genomic structure of the human gene for protein kinase A regulatory subunit R1‐beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred (2004) (18)
The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial (2012) (18)
Reninoma: The Importance of Renal Vein Renin Ratios for Lateralisation and Diagnosis (2013) (18)
The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway (2019) (18)
Laparoscopic Adrenalectomy (1996) (18)
Primary aldosteronism: from genesis to genetics (2003) (18)
How to measure home blood pressure: Recommendations for healthcare professionals and patients. (2016) (17)
Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism. (2020) (17)
CORTISOL PRODUCTION BY ALDOSTERONE‐PRODUCING ADENOMAS IN VITRO (1993) (17)
Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma (2011) (17)
Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia (2000) (17)
New Advances in the Diagnostic Workup of Primary Aldosteronism (2017) (17)
Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells. (2015) (16)
Taste and Hypertension in Humans: Targeting Cardiovascular Disease. (2016) (16)
Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels (2019) (16)
In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes. (1997) (16)
DIFFERENT ALLELIC PATTERNS AT CHROMOSOME 11q13 IN PAIRED ALDOSTERONE‐PRODUCING TUMOURS AND BLOOD DNA (1996) (16)
Cytoskeletal changes in Eimeria bovis-infected host endothelial cells during first merogony (2008) (16)
Central Hemodynamics and Cardiovascular Risk in Nondippers (2011) (15)
Managing hypertension during the COVID-19 pandemic (2020) (15)
A Randomised Controlled Trial of Medication Liaison Services—Acceptance and Use by Health Professionals (2002) (15)
Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion (2015) (14)
Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism (2020) (14)
Is it time to screen all patients with hypertension for primary aldosteronism? (2018) (14)
No evidence for coding region mutations in the retinoblastoma‐associated Kruppel‐associated box protein gene (RBaK) causing familial hyperaldosteronism type II (2006) (14)
Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. (1994) (14)
Improving the success and reliability of adrenal venous sampling: focus on intraprocedural cortisol measurement. (2012) (14)
The Role of Exercise in Patients with Obesity and Hypertension (2020) (13)
Renin gene polymorphism associated with aldosterone responsiveness to the renin-angiotensin system in patients with aldosterone-producing adenomas. (1993) (13)
Rationale and design of a randomized study to determine the value of central Blood Pressure for GUIDing managEment of hypertension: the BP GUIDE study. (2012) (13)
Expression of 11betaHSD-2 in human adrenal cortical carcinoma and adenoma. (1998) (12)
HYBRID GENE OR HYBRID STEROIDS IN THE DETECTION AND SCREENING FOR FAMILIAL HYPERALDOSTERONISM TYPE I (1995) (12)
The renaissance of primary aldosteronism: what has it taught us? (2013) (12)
Primary aldosteronism in 2011: Towards a better understanding of causation and consequences (2012) (12)
Karyotypic abnormalities in benign adrenocortical tumors producing aldosterone. (1993) (12)
The mineralocorticoid receptor—an emerging player in metabolic syndrome? (2021) (12)
Aldosterone Excess and Resistant Hypertension: Investigation and Treatment (2014) (12)
Inhibition of endopeptidase EC 3.4.24.11 by candoxatril lowered blood pressure and increased urinary but not plasma atrial natriuretic peptide in essential hypertension (1993) (11)
Identifying drug-related readmissions: is there a better way of assessing the contribution of adverse medication events? (2000) (11)
Primary Hyperaldosteronism Somatic Mutations Affecting the Selectivity Filter of KCNJ 5 Are Frequent in 2 Large Unselected Collections of Adrenal Aldosteronomas (2012) (11)
RENIN GENE POLYMORPHISM ASSOCIATED WITH ALDOSTERONE RESPONSIVENESS TO THE RENINANGIOTENSIN SYSTEM IN PATIENTS WITH ALDOSTERONE‐PRODUCING ADENOMAS (1994) (11)
Biochemical, Histopathological and Genetic Characterization of Posture Responsive and Unresponsive APAs. (2020) (11)
Hyperdynamic Right Heart Function in Graves' Hyperthyroidism Measured by Echocardiography Normalises on Restoration of Euthyroidism. (2017) (11)
2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action (2022) (11)
Detecting primary aldosteronism in Australian primary care: a prospective study (2022) (10)
Primary Aldosteronism (2014) (10)
Guiding Hypertension Management Using Central Blood Pressure: Effect of Medication Withdrawal on Left Ventricular Function. (2015) (9)
Primary aldosteronism and potassium channel mutations (2013) (9)
Primary mineralocorticoid excess syndromes (2006) (9)
Out‐of‐office and central blood pressure for risk stratification: a cross‐sectional study in patients treated for hypertension (2012) (9)
The renin gene and aldosterone-producing adenomas. (1994) (9)
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma. (1996) (9)
1999 Guide to Management of Hypertension for Doctors (1999) (8)
Epstein-Barr virus-induced secondary high-grade transformation of Sjögren's syndrome-related mucosa-associated lymphoid tissue lymphoma. (2013) (8)
Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study). (2017) (8)
The aldosterone-renin ratio and primary aldosteronism. (2002) (8)
The Cl−/HCO3− exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism (2020) (8)
Familial hyperaldosteronism type 1 in pregnancy (2009) (7)
GENETICS OF PRIMARY ALDOSTERONISM (1994) (7)
Aldosterone excess, hypertension, and chromosome 7p22: evidence continues to mount. (2007) (7)
PCR‐SSCP ANALYSIS OF THE PROMOTER REGION OF THE RENIN GENE IN PATIENTS WITH ALDOSTERONE‐PRODUCING ADENOMAS (1996) (7)
How common is adrenal-based mineralocorticoid hypertension? (2000) (7)
Adrenal venous sampling for differentiating unilateral from bilateral primary aldosteronism: still the best, but could be better. (2015) (6)
Evidence for persistent dysfunction of wild‐type aldosterone synthase gene in glucocorticoid‐treated familial hyperaldosteronism type I (1997) (6)
Primary Aldosteronism: Diagnosis and Management (2013) (5)
Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism (2004) (5)
Calibrators for measuring aldosterone by liquid chromatography-tandem mass spectrometry. (2012) (5)
Genetic Forms of Primary Aldosteronism (2007) (5)
The aldosterone-renin ratio and primary aldosteronism [3] (multiple letters) (2002) (5)
Reduced renal extraction of atrial natriuretic peptide in primary aldosteronism. (1995) (5)
Importance of ambulatory blood pressure in hypertension management (2012) (5)
The Aldosterone–Renin Ratio: Role and Problems (2014) (4)
Uncontrolled hypertension: beyond pharmacological treatment (2009) (4)
Are thiazide diuretics preferred as first‐line therapy for hypertension? An appraisal of The Antihypertensive and Lipid‐lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2003) (4)
Using human urinary extracellular vesicles to study physiological and pathophysiological states and regulation of the sodium chloride cotransporter (2022) (4)
Familial hyperaldosteronism type II (2020) (4)
Effect of sodium restriction on blood pressure, fluid status and proteinuria in CKD patients: results of a randomised crossover trial and 6-month follow-up (2013) (4)
RENAL EXTRACTION OF ATRIAL NATRIURETIC PEPTIDE IN UNILATERAL RENAL ARTERY STENOSIS (1994) (4)
ClearSight™ finger cuff versus invasive arterial pressure measurement in patients with body mass index above 45 kg/m2 (2021) (4)
The utility of renal venous renin studies in selection of patients with renal artery stenosis for angioplasty: a retrospective study (2015) (3)
Aortic stiffness, but not central or brachial blood pressures, predict physical quality of life (2010) (3)
Hyperreninemic hypertension following presumed abdominal trauma (2011) (3)
Cochrane and the salt debate (2003) (3)
ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II) (2017) (3)
ANALYSIS OF THE RENIN GENE IN PATIENTS WITH ALDOSTERONE‐PRODUCING ADENOMAS BY POLYMERASE CHAIN REACTION‐SINGLE STRANDED CONFORMATIONAL POLYMORPHISMS AND LONG POLYMERASE CHAIN REACTION (1995) (3)
Long-PCR of the ANP gene and PCR-SSCP analysis of the proximal promoter region of the ANP gene in patients with aldosterone producing adenoma. (1995) (3)
New guidelines with few takers: will the new American guidelines ever be accepted? (2018) (3)
Evidence Continues to Mount (2007) (3)
IMPACT OF DIFFERENT DIAGNOSTIC CRITERIA DURING ADRENAL VEIN SAMPLING ON REPRODUCIBILITY OF SUBTYPE DIAGNOSIS IN PATIENTS WITH PRIMARY ALDOSTERONISM: PP.18.194 (2010) (3)
Comparison of ambulatory and clinic blood pressure targets in obese and non obese subjects: a high blood pressure research council of Australia initiative (2010) (2)
OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION. (2016) (2)
Aldosterone-producing adenoma associated with non-suppressed renin: a case series (2021) (2)
Potassium Channel Mutations and Human Disease: Focus on Adrenal Hypertension (2017) (2)
Measurement of blood pressure during a single bout of low intensity exercise identifies patients with masked hypertension (2010) (2)
Brachial and Central Blood Pressure Respond Differently to Postural Changes in Patients with Treated Hypertension (2011) (2)
A-001 ALDOSTERONE EXCESS STIMULATES SALT APPETITE IN PATIENTS WITH ALDOSTERONE PRODUCING ADENOMA (2011) (2)
Diagnosis of aldosterone-producing adenoma: Aldosterone/renin ratio and adrenal venous sampling (1998) (2)
The expanding role of aldosterone excess in cardiovascular disease (2006) (2)
What is new in the management of resistant hypertension (2011) (2)
9B.03: A NOVEL INSERTIONAL SOMATIC KCNJ5 MUTATION IN AN AUSTRALIAN PATIENT WITH AN ALDOSTERONE PRODUCING ADENOMA (2015) (2)
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study. (2022) (1)
A Novel Insertional Somatic Kcnj5 Mutation in An Australian Patient with An Aldosterone-Producing Adenoma (2015) (1)
Response to ‘More fuel in the obesity paradox debate’: fatness, fitness, stiffness and blood pressure (2013) (1)
Effect of moxonidine on the aldosterone/renin ratio calculated by both plasma renin activity and direct renin concentration in healthy male volunteers (2017) (1)
IMPROVING HYPERTENSION CONTROL BY MOLECULAR STRATIFICATION OF FIRST-LINE NON-RESPONDERS USING RAAS TRIPLE-A TESTING (2019) (1)
Urinary clonidine suppression testing for the diagnosis of pheochromocytoma (2015) (1)
Fast Facts: Hypertension (1999) (1)
Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity (2005) (1)
No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample (2005) (1)
The Relationship Between the Aldosterone-to-Renin Ratio and Blood Pressure in Young Adults: A Longitudinal Study (2021) (1)
Rapid cortisol measurement aids in real-time confirmation of successful cannulation during adrenal venous sampling (2007) (1)
OS 35-05 MEASUREMENT OF ANGIOTENSIN II AT EQUILIBRIUM IN THE DIAGNOSTIC WORKUP OF PRIMARY ALDOSTERONISM - IMPACT OF PATIENT POSITIONING AND ACE INHIBITOR TREATMENT (2016) (1)
Can unilateral forms of primary aldosteronism be excluded with confidence preoperatively by methods other than adrenal venous sampling? The search continues. (2020) (1)
Semi-automated analysis of aldosterone by liquid chromatography-tandem mass spectrometry: the new gold standard (2008) (1)
Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism (2015) (1)
Is the phase of the menstrual cycle important when screening for primary aldosteronism (PAL) in women, and does renin assay method matter? (2010) (1)
Acute Intravenous NaCl and Volume Expansion Reduces Sodium-Chloride Cotransporter Abundance and Phosphorylation in Urinary Extracellular Vesicles (2022) (1)
Is It the Beginning of the End for the Recumbent Saline Infusion Test? (2016) (1)
Aldosterone Impact of Different Diagnostic Criteria During Adrenal Vein Sampling on Reproducibility of Subtype Diagnosis in Patients With Primary Aldosteronism (2010) (1)
2011 Draft Position Statement on the Use of Ambulatory Blood Pressure Monitoring in Australia: National Heart Foundation (NHF) & High Blood Pressure Research Council (HBPRCA) (2011) (1)
CLCN2 chloride channel mutations in familial hyperaldosteronism type II (2018) (1)
Relationship of hypertension severity to hybrid gene crossover point in familial hyperaldosteronism type 1 (FH-1) (2001) (1)
PP.LB03.01: MINERALOCORTICOID RECEPTOR ACTIVATION ACUTELY INCREASES EXPRESSION AND PHOSPHORYLATION OF THE THIAZIDE SENSITIVE SODIUM CHLORIDE COTRANSPORTER IN HUMANS (2015) (1)
Randomized trial on the effect of oral potassium chloride supplementation on the thiazide-sensitive sodium chloride cotransporter in healthy adults (2023) (1)
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. (2022) (1)
Frontiers in research review: aldosterone and salt: heart and kidney-introduction (2013) (1)
THE ADRENAL VEIN SAMPLING INTERNATIONAL STUDY (AVIS) ON USE AND INTERPRETATION OF ADRENAL VEIN SAMPLING FOR DIFFERENTIATING THE MAJOR SUBTYPES OF PRIMARY ALDOSTERONISM: 8D.07 (2011) (1)
Genetic basis of familial hyperaldosteronism type II: Further evidence of linkage at chromosome 7p22 (2007) (1)
Mineralocorticoid receptor activation acutely increases expression and phosphorylation of the thiazide sensitive sodium chloride cotransporter in humans (2015) (1)
9B.04: DOES CONTRALATERAL SUPPRESSION AT ADRENAL VENOUS SAMPLING PREDICT OUTCOME FOLLOWING UNILATERAL ADRENALECTOMY FOR PRIMARY ALDOSTERONISM? A RETROSPECTIVE STUDY (2015) (1)
OS 35-05 MEASUREMENT OF ANGIOTENSIN II AT EQUILIBRIUM IN THE DIAGNOSTIC WORKUP OF PRIMARY ALDOSTERONISM - IMPACT OF PATIENT POSITIONING AND ACE INHIBITOR TREATMENT. (2016) (1)
1095 SOMATIC MUTATIONS AFFECTING THE SELECTIVITY FILTER OF KCNJ5 ARE FREQUENT IN ALDOSTERONE-PRODUCING ADENOMAS AND ASSOCIATED WITH LACK OF ALDOSTERONE RESPONSE TO UPRIGHT POSTURE (2012) (1)
Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversion (2005) (1)
Overview of mineralocorticoid excess syndromes (2005) (1)
A young man with severe hypertension (2018) (1)
Examination of Chromosome 7P22 candidate genes RPA3, ZNF12 and GLCCl1 in familial hyperaldosteronism typeII (2009) (1)
JHH change in leadership (2015) (1)
Concomitant autonomous cortisol secretion by aldosterone-producing adenoma: the utility of plasma metadrenaline to assess lateralization during adrenal venous sampling (2015) (1)
Examination of candidate genes at chromosome 7p22 in familial hyperaldosteronism type II (2007) (1)
SEATED SALINE SUPPRESSION TESTING FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM. A VALIDATION STUDY (2018) (1)
Biomarkers: stepping stones to firmer end points (2016) (1)
Intraprocedural cortisol testing improves adrenal vein cannulation success and diagnostic accuracy in assessment of primary aldosteronism, in a medium throughput centre. (2022) (1)
OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION. (2016) (1)
Abstract P3059: ACE S: A NOVEL ANGIOTENSIN BASED MARKER FOR MONITORING PHARMACOLOGIC ACTIVITY OF ACE INHIBITORS IN HYPERTENSIVE PATIENTS (2019) (1)
Safety and efficacy of sildenafil citrate in men with erectile dysfunction and hypertension who are taking multiple antihypertensive treatments (2003) (0)
LONG TERM EFFECT OF RENAL DENERVATION ON BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION (2011) (0)
Saline Suppression Testing Performed in Seated Patients Is Superior to Recumbent and Comparable to Fludrocortisone Suppression Testing in Diagnosing Primary Aldosteronism (2014) (0)
[BP.03.06] EFFECT OF COMBINED HORMONAL REPLACEMENT THERAPY ON THE ALDOSTERONE/RENIN RATIO IN POSTMENOPAUSAL WOMEN (2017) (0)
Aldosterone excess in hypertension. Authors' reply (2004) (0)
Reninoma - Carefully performed renal venous renin ratio studies (RVRRS) are critical for diagnosis (2004) (0)
Abstract 057: Cellular and Genetic Causes of Idiopathic Hyperaldosteronism (2017) (0)
3DE is the More Reliable Method Sequential LV Mass Measurements in Clinical Trials (2011) (0)
Prevalence of primary aldosteronism among Chinese hypertensive patients (2006) (0)
Repeat adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma (2012) (0)
Relationship between ambulatory and clinic blood pressure: a high blood pressure research council of Australia initiative (2009) (0)
THE EFFECT OF RAMIPRIL ON THE ALDOSTERONE/RENIN RATIO AND THE ALDOSTERONE/ANGIOTENSIN II RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM (2021) (0)
[OP.3A.04] ADRENAL HEMORRHAGE FOLLOWING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM: A SIX-CENTER EXPERIENCE (2016) (0)
ESSA : Exercise and Hypertension (2011) (0)
A1728 Measurement of aldosterone: comparison of liquid chromatography-tandem mass spectrometry with radioimmunoassay in screening and confirmatory testing for primary aldosteronism (2018) (0)
rtension, obesity, sleep apnea, and aldosterone: theory and therapy. (1991) (0)
RELATIONSHIP BETWEEN THE HYPOTHALMIC-PITUITARY-ADRENOCORTICAL AXIS ACTIVITY AND THE CHARACTERISTICS OF ALDOSTERONE-PRODUCING ADENOMAS (2020) (0)
From the 31 st Annual Scientific Meeting of the High Blood Pressure Research Council of Australia (2009) (0)
Mineralocorticoids Increase Abundance and Phosphorylation of the Thiazide Sensitive Sodium-Chloride Cotransporter in Humans Via the Wnk-Spak Pathway (2016) (0)
Central blood pressure for guiding the management of hypertension (bp Guide): study design and preliminary results (2009) (0)
Abstract P612: The AA2-Ratio: Towards Improved Screening for Primary Aldosteronism (2016) (0)
A1711 Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study (2018) (0)
In Primary Aldosteronism Acute Potassium Chloride Supplementation Suppresses Abundance and Phosphorylation of the Sodium-Chloride Cotransporter (2022) (0)
Primary Aldosteronism (PAL) (2004) (0)
ALDOSTERONE REDUCTION BY UNILATERAL ADRENALECTOMY REDUCES SALT APPETITE IN PATIENTS CURED OF PRIMARY ALDOSTERONISM: LB2.4 (2011) (0)
Brachial and Central Blood Pressure Is Associated With Obesity: Relation to Large Artery Stiffness (2009) (0)
A1868 Seated saline suppression testing for the diagnosis of primary aldosteronism – a validation study (2018) (0)
OS 33-06 IN PATIENTS WITH PRIMARY ALDOSTERONISM, OBSTRUCTIVE SLEEP APNOEA IMPROVES WITH TREATMENT BY ADRENALECTOMY OR MEDICAL THERAPY (2016) (0)
A semi-automated liquid chromatogrpahy-tandem mass spectrometry (LC-MS/MS) method for the measurement of plasma aldosterone (2010) (0)
Further evidence of linkage at 7p22 with familial hyperaldosteronism type II and exclusion of genetic defects in the RBAK coding regions (2006) (0)
Sequence variants in ARMC5 are not implicated in familial hyperaldosteronism type II (2017) (0)
A need to re-focus on precision of screening and diagnostic tests in primary aldosteronism (2012) (0)
PS-BPC10-7: EFFECT OF ORAL POTASSIUM CHLORIDE SUPPLEMENTATION ON THE THIAZIDE-SENSITIVE SODIUM CHLORIDE COTRANSPORTER (NCC) IN HEALTHY HUMANS: A RANDOMISED CROSSOVER TRIAL (2023) (0)
Introduction (2013) (0)
Editors choice: recent highlights from the journal of human hypertension (2010) (0)
PP.23.03: SHOULD ALDOSTERONE SUPPRESSION TESTS BE CONDUCTED DURING A PARTICULAR PHASE OF THE MENSTRUAL CYCLE, AND, IF SO, WHICH PHASE? (2015) (0)
Aldosterone and Primary Aldosteronism: Star Performers in Hypertension Research. (2021) (0)
Commentary: Effect of aldosterone antagonism in hypertensive patients with diastolic heart failure (2004) (0)
Primary aldosteronism (PAL) at Princess Alexandra Hospital: Correcting Kaplan (2001) (0)
OS 35-08 DOES ADRENOCORTICOTROPIC HORMONE (ACTH) ADMINISTRATION IMPROVE THE DIAGNOSTIC PERFORMANCE OF ADRENAL VEIN SAMPLING FOR PRIMARY ALDOSTERONISM? (2016) (0)
Can liquid chromatography-tandem mass spectrometry solve the problem of aldosterone measurement? (2007) (0)
Primary aldosteronism is associated with abnormal myocardial function independent of blood pressure (2004) (0)
Selective Serotonin Reuptake Inhibitor Antidepressants May Interfere with the Diagnostic Work Up of Primary Aldosteronism (2011) (0)
2.30 Diagnostic workup of primary aldosteronism (2012) (0)
A positive renal vein renin lateralisation ratio independently predicts blood pressure benefit from angioplasty in renal artery stenosis: a retrospective study (2015) (0)
Using central blood pressure to guide therapy in hypertension: BP GUIDE Study design and initial findings (2009) (0)
Characterisation of a novel duplication mutation in KCNJ5 from a patient with an aldosterone producing adenoma (2015) (0)
654 MEASUREMENT OF ALDOSTERONE AND CORTISOL BY HPLC-TANDEM MASS SPECTROMETRY: COULD THIS IMPROVE DECISION MAKING IN PRIMARY ALDOSTERONISM? (2012) (0)
Does Correction of Aldosteronism by Unilateral Adrenalectomy in Patients with Aldosterone-Producing Adenoma Reduce Salt Appetite? (2011) (0)
Prevalence and genetic basis of primary aldosteronism: Insights gained from studies of familial forms (2001) (0)
Simultaneous Measurement of Aldosterone and Cortisol in Plasma by HPLC-Tandem Mass Spectrometry: Application to Sports Medicine Studies (2009) (0)
Mineralocorticoid excess syndromes (0)
A13439 Cellular and Genetic Causes of Idiopathic Hyperaldosteronism (2018) (0)
Improved quality of life following unilateral laparoscopic adrenalectomy in patients with unilateral primary aldosteronism (2010) (0)
Possible changes in the return period of loss associated with European wind storms in a future climate (2009) (0)
Dietary Sodium and Aldosterone Levels Are Related to Severity of Obstructive Sleep Apnea in Patients with Resistant Hypertension (2011) (0)
Primary aldosteronism : an important, potentially curable form of human hypertension (0)
[OP.LB01.11] MEASUREMENT OF ANGIOTENSIN II AT EQUILIBRIUM IN THE DIAGNOSTIC WORKUP OF PRIMARY ALDOSTERONISM. IMPACT OF PATIENT POSITIONING AND ACE INHIBITOR TREATMENT (2016) (0)
Response to Letter to the Editor: "Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism". (2019) (0)
Withdrawn: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. (2009) (0)
Abstract P2074: Improving Hypertension Control By Molecular Stratification Of First-Line Non-Responders Using RAAS Triple-A Testing (2019) (0)
Assessment of possible changes in return period and ranking of losses associated with European wind storms in a future climate (2010) (0)
Relevance of plasma aldosterone responsiveness to upright posture, hybrid steroids and histology of Aldosterone-Producing Adenomas (APAs) to the finding of KCNJ5 mutations in some APAs (2012) (0)
EFFECTS OF ACUTE SODIUM LOADING ON NCC ABUNDANCE AND PHOSPHORYLATION IN HYPERTENSIVES WITH RAISED ALDOSTERONE TO RENIN RATIO (ARR) IN HUMAN URINARY EXOSOMES (2019) (0)
Comparison of central blood pressure estimated by upper-arm cuff-based device with radial tonometry (2015) (0)
QUANTITATIVE mRNA ANALYSIS OF THE THIAZIDE-SENSITIVE SODIUM CHLORIDE COTRANSPORTERS IN URINARY EXOSOMES FROM NORMAL CONTROLS AND PATIENTS WITH PRIMARY ALDOSTERONISM (2017) (0)
[LB.03.20] APPLICATIONS OF RAS-EQUILIBRIUM-ANALYSIS IN THE DIAGNOSIS OF PRIMARY ALDOSTERONISM AND BIOCHEMICAL PROFILING OF HYPERTENSION (2017) (0)
Too much of a good thing: A woman with hypertension and hypokalemia - Commentary (2009) (0)
Non-surgical therapy of primary aldosteronism (2011) (0)
Hypertension Repeating adrenal vein sampling when neither aldosterone / cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma (2013) (0)
Assessment of clinical performance of a currently available immunoassay for aldosterone, achieved by comparison with a specific, precise aldosterone mass spectrometry assay (2009) (0)
No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II (2006) (0)
Book Review - Secondary Hypertension: Clinical Presentation, Diagnosis and Treatment (2004) (0)
Australian Registry and Guidelines: Experience and Recommendations (2011) (0)
Aldosterone, gut microbiome and hypertension: selected papers from APCH 2019 (2021) (0)
Diagnosis of primary aldosteronism (2008) (0)
Introduction: Aldosterone and salt: heart and kidney. (2013) (0)
Aldosteronism, Primary: Epidemiology and Screening (2014) (0)
SUPINE CLINIC BLOOD PRESSURE IS RAISED IN HYPERTENSIVE NON-DIPPERS: A NOVEL TEST TO DETERMINE DIPPER STATUS? (2009) (0)
In population studies in persons aged 50-60 years (framingham), higher aldosterone, lower renin and higher aldosterone/renin ratio predicted rising blood pressure, the genetic basis of which is possibly shared with familial hyperaldosteronism type II (2009) (0)
Genotyping and expression studies of 7p22 candidate genes in familial hyperaldosteronism type II (2008) (0)
Potassium channels, herg mutations and hormonal secretion: possible involvement in primary aldosteronism (2008) (0)
Primary aldosteronism: a common cause of hypertension with a genetic basis (2004) (0)
DEFINING THE OPTIMAL CUT-OFF PLASMA ALDOSTERONE LEVEL MEASURED BY IMMUNOASSAY FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM USING SEATED SALINE SUPPRESSION TEST (2019) (0)
In hereditary hyperkalemic hypertension, genetic heterogeneity, salt intake and medications affet phenotype and delay diagnosis. Will genetic testing resolve this? (2007) (0)
The author's reply: The importance of knowing the timing within the menstrual cycle in nonmenopausal hypertensive women in the diagnostic workup for primary aldosteronism (2016) (0)
4.5 Linkage of Familial Hyperaldosteronism Type II at Chromosome 7p22 in Two Italian Families (2008) (0)
AMBULATORY BLOOD PRESSURE MONITORING IN AUSTRALIA: 2011 DRAFT POSITION STATEMENT: 1A.05 (2011) (0)
Prevalence of Klhl3 and Cul3 Mutations in Familial Hyperkalemic Hypertension (2014) (0)
Abstract P251: Angiotensin Based Biomarkers for Molecular Profiling and Drug Efficacy Monitoring in Hypertension (2018) (0)
Lipoprotein (a) is Elevated in Patients with Renovascular Hypertension, but not in Patients with Primary Aldosteronism (2007) (0)
Responsiveness of Aldosterone to Upright Posture, Even When Measured by a Highly Accurate Mass Spectrometric Method, Cannot Replace Adrenal Venous Sampling in the Differentiation of Unilateral and Bilateral Forms of Primary Aldosteronism (Pal) (2011) (0)
OS 35-08 DOES ADRENOCORTICOTROPIC HORMONE (ACTH) ADMINISTRATION IMPROVE THE DIAGNOSTIC PERFORMANCE OF ADRENAL VEIN SAMPLING FOR PRIMARY ALDOSTERONISM? (2016) (0)
Quality-of-Life Aspects of Primary Aldosteronism (2014) (0)
The evolution of primary aldosteronism: From genesis to genetics (2001) (0)
Abstract 2525: Cardiovascular Effects of Unilateral Adrenalectomy are Superior to Those of Aldosterone Antagonist Treatment in Primary Aldosteronism (2007) (0)
Willingness to be tested for a secondary cause of hypertension: a survey of the Australian general community. (2022) (0)
Menard and tolerance of spironolactone in essential hypertension. (1995) (0)
The rebirth of primary aldosteronism (2004) (0)
ADMINISTRATION OF EXOGENOUS MINERALOCORTICOIDS AND POTASSIUM IS ASSOCIATED WITH A REDUCTION IN PENDRIN ABUNDANCE IN URINARY EXOSOMES FROM PATIENTS WITH PRIMARY ALDOSTERONISMS (2019) (0)
Diagnostic workup of primary aldosteronism (2011) (0)
451 REPEAT ADRENAL VEIN SAMPLING WHEN NEITHER ALDOSTERONE/CORTISOL RATIO EXCEEDS PERIPHERAL YIELDS A HIGH INCIDENCE OF ALDOSTERONE-PRODUCING ADENOMA (2012) (0)
Ambulatory blood pressure monitoring in Australia: 2011 draft position statement (2011) (0)
New Germ-Line Mutations and a Rare Coding Snp Within Kcnj5 in "apparently Sporadic" Primary Aldosteronism: a Possible Role in Pathogenesis (2014) (0)
Angiotensin II (AngII) receptors in AngII-responsive (AngII-R) and angII-unresponsive (AngII-U) aldosterone-producing adenoma (APA) (2000) (0)
Further evidence of linkage at 7p22 with familial hyperaldosteronism type II (2005) (0)
Relationship Between the Aldosterone-to-Renin Ratio and Blood Pressure in Young Adults: A Longitudinal Study (2021) (0)
S-13-5: UPDATES ON FAMILIAL HYPERALDSOTERONISM (2023) (0)
Concerns that aldosterone will suppress enough during salt loading to miss the diagnosis in patients with angiotensin Ii-responsive aldosterone-producing adenoma appear to be unfounded (2009) (0)
Angiotensin II (Angll) receptors in angll-response (Angll-R) and angll-unresponsive (Angll-U) aldosterone-producing adenoma (APA) (2000) (0)
[BP.12.02] PLASMA POTASSIUM NEGATIVELY EFFECTS ABUNDANCE OF THE THAIZIDE SENSITIVE SODIUM-CHLORIDE COTRANSPORTER IN HUMANS (2017) (0)
PENDRIN REDUCTION IS ASSOCIATED WITH ACUTE INTRAVENOUS SODIUM CHLORIDE LOADING IN PATIENTS WITH PRIMARY ALDOSTERONISM (2021) (0)
Content and delivery preferences for information to support the management of high blood pressure (2022) (0)
Measurement of aldosterone and cortisol by HPLC-Tandem Mass Spectrometry: could this improve decision making in primary aldosteronism? (2012) (0)
Evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in families from Australia, South America and Italy (2008) (0)
Principal findings from the first randomised study to determine the value of central blood pressure for guiding management of hypertension: The BP guide study (2012) (0)
Recent Framingham data suggest that patients with autonomous aldosterone secretion will be well represented in the population of "essential" hypertensives aged over 50 years, and that they share a genetic basis (2009) (0)
PP.23.02: COULD THE PHASE OF THE MENSTRUAL CYCLE AFFECT THE RESULTS OF ADRENAL VENOUS SAMPLING AND SUBTYPING OUTCOME OF PRIMARY ALDOSTERONISM? (2015) (0)
APPLICATION OF A NOVEL EQUILIBRIUM ANGIOTENSIN II ASSAY IN SCREENING AND CONFIRMATORY TESTING FOR PRIMARY ALDOSTERONISM: A PILOT STUDY (2018) (0)
CMF5 – Primary Hyperaldosteronism (2012) (0)
214 Renal clearance of atrial natriuretic peptide is possibly enhanced in renal artery stenosis and may be of diagnostic value (1993) (0)
The aldosterone-renin ratio and primary aldosteronism. Authors' reply (2002) (0)
REDUCED NACL COTRANSPORTER ABUNDANCE AND PHOSPHORYLATION IN URINARY EXTRACELLULAR VESICLES IN RESPONSE TO KCL SUPPLEMENTS IN HEALTHY ADULTS MAINTAINED ON A HIGH-NA+ LOW-K+ DIET: A (2022) (0)
A specific, precise aldosterone mass spectrometry assay to assess clinical performance of a currently available immunoassay (2009) (0)
Aldosterone excess in hypertension - Reply (2004) (0)
Cost Effectiveness of Hypertension Management Guided by Central Blood Pressure Measurement: Health Economic Evaluation of the Bpguide Study (2014) (0)
Adrenal cortico-medullary interactions: pheochromocytoma-associated cortical hyperplasia and benign neoplasia (2007) (0)
14. USING CENTRAL BLOOD PRESSURE TO GUIDE THERAPY IN HYPERTENSION: BP GUIDE STUDY DESIGN AND INITIAL FINDINGS (0)
Suppression testing for diagnosis of primary aldosteronism will not lead to overlooking angiotensin-responsive aldosterone-producing adenoma (2009) (0)
LBPS 02-37 ADRENAL HEMORRHAGE FOLLOWING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM: A SIX-CENTER EXPERIENCE. (2016) (0)
BIOCHEMICAL, HISTOPATHOLOGICAL, AND GENETIC CHARACTERIZATION OF POSTURE RESPONSIVE AND UNRESPONSIVE ALDOSTERONE-PRODUCING ADENOMAS (2021) (0)
Title: Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An (2008) (0)
Unilateral adrenalectomy in bilateral primary aldosteronism can be highly beneficial and should not be excluded as a treatment option: observations from 22-Years experience within a single center (2009) (0)
PP080—The role of the KCNJ5 potassium channel variants in aldosterone release (2013) (0)
Familial hyperaldosteronism type II (FH-II) is more common than type I (FH-I) and demonstrates linkage to chromosome 7p22 (2004) (0)
The utility of renal vein renin studies in selection of patients with renal artery stenosis for revascularization: A retrospective study (2015) (0)
Clinical, biomedical and radiological overlap between familial hyperaldosteronism type I and II: importance of genetic testing (2000) (0)
Measurement of aldosterone (aldo) by semi-automated liquid chromatography-tandem mass spectrometry (LC-MS/MS) (2008) (0)
A7813 Variations in abundance of urinary exosomal renal sodium transporters in response to mineralocorticoid administration and oral salt loading and in relation to baseline plasma aldosterone and potassium (2018) (0)
Differential Effect of Renal Sympathetic Denervation on Central and Peripheral Blood Pressure (2013) (0)
[PP.07.06] EFFECT OF MOXONIDINE ON THE ALDOSTERONE/RENIN RATIO CALCULATED BY BOTH PLASMA RENIN ACTIVITY AND DIRECT RENIN CONCENTRATION IN HEALTHY MALE VOLUNTEERS (2017) (0)
Importance of ambulatory blood pressure in hypertension management (2013) (0)
Application of long-PCR to the screening and detection of familial hyperaldosteronism type I (1996) (0)
Th-W51:5 Lipoprotein (A) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism (2006) (0)
ACE-S (2019) (0)
Adrenocorticotropic hormone administration improves the diagnostic performance of adrenal vein sampling (2016) (0)
624 A NEED TO RE-FOCUS ON PRECISION OF SCREENING AND DIAGNOSTIC TESTS IN PRIMARY ALDOSTERONISM (2012) (0)
OS 33-06 IN PATIENTS WITH PRIMARY ALDOSTERONISM, OBSTRUCTIVE SLEEP APNOEA IMPROVES WITH TREATMENT BY ADRENALECTOMY OR MEDICAL THERAPY. (2016) (0)
PROCEEDINGS OF THE HIGH BLOOD PRESSURE RESEARCH COUNCIL OF AUSTRALIA (1984) (0)
57 OBSTRUCTIVE SLEEP APNEA IS PREVALENT IN PRIMARY ALDOSTERONISM: 3D MAGNETIC RESONANCE IMAGING TO STUDY IMPROVEMENT WITH ALDOSTERONE BLOCKADE - PRELIMINARY FINDINGS (2012) (0)
In a single centre, experience over 22 years suggests that unilateral adrenalectomy can be useful in selected patients with primary aldosteronism due to bilateral disease (2009) (0)
Effect of oral contraception on screening tests for primary aldosteronism: a 10-year longitudinal study. (2023) (0)
The hypertensive accountant (2006) (0)
Cardiac Dimensions Are Largely Determined by Dietary Salt in Patients with Primary Aldosteronism, But Not in Patients with Essential Hypertension (2011) (0)
THE EFFECT OF RAMIPRIL ON THE ALDOSTERONE/RENIN RATIO AND ALDOSTERONE/ANGIOTENSIN II RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM (2019) (0)
Faculty Opinions recommendation of Analysis of unilateral adrenal hyperplasia with primary aldosteronism from the aspect of messenger ribonucleic acid expression for steroidogenic enzymes: a comparative study with adrenal cortices adhering to aldosterone-producing adenoma. (2006) (0)
Linkage analysis for familial hyperaldosteronism type II: Exclusion of linkage to the aldosterone synthase and angiotensin II receptor genes (1998) (0)
Familial hyperaldosteronism type II - evidence for linkage at chromosome 7p22 in families from Australia, South America and Italy (2008) (0)
[The significance of antacids and their proper dosage]. (1981) (0)
Some evidence for a chronic (but not acute) effect of aldosterone on procollagen levels in humans (2003) (0)
Correction: ClearSight™ finger cuff versus invasive arterial pressure measurement in patients with body mass index above 45 kg/m2 (2023) (0)
Cochrane and the salt debate. Author's reply (2003) (0)
PS 02-33 QUANTITATIVE mRNA ANALYSIS OF THIAZIDE SODIUM COTRANSPORTER IN URINARY EXOSOMES FROM NORMAL CONTROLS AND PATIENTS WITH PRIMARY ALDOSTERONISM (2016) (0)
Strengthening a societal tie and other new initiatives for 2019 (2019) (0)
Evaluation of the Antihypertensive Efficacy of Eplerenone and Amlodipine in Older Patients with Systolic Hypertension (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael Stowasser?

Michael Stowasser is affiliated with the following schools:

Michael Stowasser's Academic­Influence.com Rankings

Michael Stowasser's Degrees

Similar Degrees You Can Earn

Why Is Michael Stowasser Influential?

Michael Stowasser's Published Works

Published Works

What Schools Are Affiliated With Michael Stowasser?

Michael Stowasser's AcademicInfluence.com Rankings